141 related articles for article (PubMed ID: 8509129)
1. Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
Nandhini D; Maneemegalai S; Elangovan V; Sekar N; Govindasamy S
Indian J Biochem Biophys; 1993 Feb; 30(1):73-6. PubMed ID: 8509129
[TBL] [Abstract][Full Text] [Related]
2. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
3. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
4. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
5. In vivo insulin-mimetic activity of [N,N'-1,3-propyl-bis(salicyladimine)]oxovanadium(IV).
Xie M; Xu G; Li L; Liu W; Niu Y; Yan S
Eur J Med Chem; 2007 Jun; 42(6):817-22. PubMed ID: 17343957
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Shinde UA; Mehta AA; Goyal RK
Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
[TBL] [Abstract][Full Text] [Related]
8. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
9. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Dziga D; Kordowiak AM
Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats.
Krosniak M; Zachwieja Z; Filipek B; Zygmunt M; Grybos R
Arch Pharm (Weinheim); 2001 Dec; 334(12):388-92. PubMed ID: 11852534
[TBL] [Abstract][Full Text] [Related]
11. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats.
Yuen VG; Pederson RA; Dai S; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1996 Sep; 74(9):1001-9. PubMed ID: 8960391
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound.
Kordowiak AM; Trzos R; Grybos R
Horm Metab Res; 1997 Mar; 29(3):101-5. PubMed ID: 9137978
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic and antihyperglycemic effect of Begonia malabarica Lam. in normal and streptozotocin induced diabetic rats.
Pandikumar P; Babu NP; Ignacimuthu S
J Ethnopharmacol; 2009 Jul; 124(1):111-5. PubMed ID: 19443148
[TBL] [Abstract][Full Text] [Related]
15. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats.
Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ
Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949
[TBL] [Abstract][Full Text] [Related]
16. Effect of an aqueous extract of Phaseolus vulgaris on plasma insulin and hepatic key enzymes of glucose metabolism in experimental diabetes.
Pari L; Venkateswaran S
Pharmazie; 2003 Dec; 58(12):916-9. PubMed ID: 14703973
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).
Yanardag R; Demirci TB; Ulküseven B; Bolkent S; Tunali S; Bolkent S
Eur J Med Chem; 2009 Feb; 44(2):818-26. PubMed ID: 18621448
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats.
Li M; Wei D; Ding W; Baruah B; Crans DC
Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514
[TBL] [Abstract][Full Text] [Related]
19. Insulin mimetic role of vanadate on plasma membrane insulin-receptors.
Sekar N; Govindasamy S
Biochem Int; 1991 Feb; 23(3):461-6. PubMed ID: 1877984
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mRNA levels of liver arginase by insulin and vanadate in experimental diabetes.
Salimuddin ; Upadhyaya KC; Raju J; Baquer NZ
Indian J Biochem Biophys; 1999 Apr; 36(2):125-8. PubMed ID: 10549172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
